Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Clinical trial NCT00034554 · COMPLETED

Trial details

NCT number: NCT00034554
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2002-03-01
Primary completion: 2004-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.